|
In the Media
May 27, 2008
[AUDIO] Craig Dees, Ph.D. interviewed by Wall Street Reporter
In a Wall Street Reporter Featured Interview, Provectus CEO Craig Dees, Ph.D. discusses
early results of clinical trials of PV-10 for melanoma and PH-10 for Psoriasis, as well as IP
issues and non-core technologies.
The audio interview is available at
The Wall Street Reporter.
April 11, 2008
Provectus Aims to Achieve Profit by 2010, Chief Says
Kelly Riddell of Bloomberg News interviews Provectus CEO Craig Dees, Ph.D. A copy of the
article is available here.
January 31, 2008
Knobias Reports on Importance of PH-10 Patent Allowance in India
Today's Knobias smallcap ClipReport features article on the importance of the recently received allowance
in India of a patent covering Provectus lead dermatology agent PH-10. A copy of the article is
available here.
January 31, 2008
Melanoma Clinical Trial Update
Genetic Engineering & Biotechnology News article gives update on Provectus phase 2 clinical trial of PV-10
for metastatic melanoma. A copy of the article is
available here.
December 13, 2007
Small Business Offers Big Advancements in Creating Cancer Drugs
A November 22, 2007 article in the business section of the Knoxville News Sentinel
highlights Provectus' innovative cancer treatment. A copy of the article is
available here.
November 23, 2007
Craig Dees, Ph.D. Comments On Anti-bacterial Wipes
A November 23rd entry in the Care-Mates(TM) Infection Protection blog
quotes Provectus CEO Craig Dees on the use of anti-bacterial soaps and wipes in the home
to help prevent infections.
The entire blog entry is available here.
| 
